MWNA
NEXI

Marshall Wace North America’s NexImmune, Inc. Common Stock NEXI Stock Holding History

Marshall Wace North America’s Portfolio NEXI Stock Details NEXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-960
Closed -$458K – 1860
2021
Q1 		$458K Buy
+960
New +$523K ﹤0.01% 1223

Other funds holding NEXI

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AO
Allen Operations New York $670M AUM 26.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marshall Wace North America's NEXI Position: Q2 2021 in Review

Marshall Wace North America sold out of NexImmune, Inc. Common Stock (NEXI) in Q2 2021, closing a stake of 960 shares — an estimated $458K sold.

Marshall Wace North America first reported a position in NEXI in Q1 2021 and held it in 1 quarter. The position peaked at $458K in Q1 2021. 42 funds tracked by Wall St. Rank hold NEXI as of Q2 2021.

  • Marshall Wace North America reported no remaining NexImmune, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Marshall Wace North America sold 960 NexImmune, Inc. Common Stock shares in Q2 2021, an estimated $458K.
  • Marshall Wace North America first reported a position in NexImmune, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Marshall Wace North America's NexImmune, Inc. Common Stock position peaked at $458K in Q1 2021.
  • 42 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q2 2021.

Based on Marshall Wace North America's 13F filing for Q2 2021, filed 13 Aug 2021.